Gotowe bibliografie tematyczne / AIDS dementia complex - Pathogenesis / Artykuły w czasopismach

Artykuły w czasopismach na temat „AIDS dementia complex - Pathogenesis”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: AIDS dementia complex - Pathogenesis.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 6 lutego 2022

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „AIDS dementia complex - Pathogenesis”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Dal Canto, M. C. "AIDS-Dementia-Complex: pathology, pathogenesis and future directions". Italian Journal of Neurological Sciences 10, nr 3 (czerwiec 1989): 277–87. http://dx.doi.org/10.1007/bf02333773.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Berman, N. E. J., J. K. Johnson, L. Raymond, E. B. Stephens, S. Joag i O. Narayan. "Pathogenesis of the aids dementia complex in the SIV model". European Neuropsychopharmacology 6 (czerwiec 1996): 22. http://dx.doi.org/10.1016/0924-977x(96)87400-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

McCaddon, A., B. Regland i C. F. Fear. "Trypsin inhibition: A potential cause of cobalamin deficiency common to the pathogenesis of Alzheimer-type dementia and AIDS dementia complex?" Medical Hypotheses 45, nr 2 (sierpień 1995): 200–204. http://dx.doi.org/10.1016/0306-9877(95)90069-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Krivine, Anne, Gilles Force, Jerome Servan, Anne-Elisabeth Cabée, Flore Rozenberg, Lucia Dighiero, Françoise Marguet i Pierre Lebon. "Measuring HIV-1 RNA and interferon-α in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex". Journal of Neurovirology 5, nr 5 (styczeń 1999): 500–506. http://dx.doi.org/10.3109/13550289909045379.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Cunningham, A. L., H. Naif, N. Saksena, G. Lynch, J. Chang, S. Li, R. Jozwiak i in. "HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype". Journal of Leukocyte Biology 62, nr 1 (lipiec 1997): 117–25. http://dx.doi.org/10.1002/jlb.62.1.117.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Perrella, O., M. Guerriero, E. Izzo, M. Soscia i P. B. Carrieri. "Interleukin-6 and granulocyte macrophage-csf in the cerebrospinal fluid from hiv infected subjects with involvement of the central nervous system". Arquivos de Neuro-Psiquiatria 50, nr 2 (czerwiec 1992): 180–82. http://dx.doi.org/10.1590/s0004-282x1992000200008.

Pełny tekst źródła
Streszczenie:
We detected the cytokines interleukin-6 (IL-6) and granulocyte macrophage-CSF (GM-CSF) by ELISA in the CSF and serum of 30 HIV-infected patients classified as AIDS dementia complex (ADC), and 20 subjects with other neurological diseases (OND). We have found a high incidence of detectable IL-6 and GM-CSF in the CSF of ADC patients compared with OND patients. No statistical differences were observed between both groups for serum IL-6 and GM-CSF levels. These results suggest an intrathecal synthesis of these cytokines and a possible involvement in the pathogenesis of ADC.
Style APA, Harvard, Vancouver, ISO itp.
7

Price, Richard W. "The AIDS dementia complex as a model for other neurodegenerative diseases: a pathogenetic conceit". Journal of the Neurological Sciences 127, nr 1 (grudzień 1994): 6–7. http://dx.doi.org/10.1016/0022-510x(94)90120-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

A.L. Sidelkovsky, P.A. Fedorov, V.V. Marusichenko i M.R. Ignatischev. "Damage to the nervous system associated with HIV infection (a clinical case)". INTERNATIONAL NEUROLOGICAL JOURNAL 16, nr 8 (10.03.2021): 53–56. http://dx.doi.org/10.22141/2224-0713.16.8.2020.221963.

Pełny tekst źródła
Streszczenie:
In Eastern Europe, at least 130 thousand new cases of HIV infection have been registered, which undoubtedly reflects the urgency of this medical problem. In our country, the average rate of human immunodeficiency infection is 58 cases per 100 thousand people. It is known that the disease is caused by an RNA-containing human immunodeficiency virus. Two types of it have been studied — HIV-1 and HIV-2, which have many subtypes. An important clinical feature of this virus is its tropism to cells of the human nervous and immune systems. The main risk group for the disease is injecting drug users, blood recipients, and people with low social responsibility. The impairment of the nervous system in AIDS is represented by the AIDS-dementia complex, acute aseptic meningitis, HIV-associated myelopathy, pathology of the peripheral nervous system, as well as the influence of opportunistic infections and neoplasms. This article presents a clinical case of lesions of the nervous system associated with HIV infection and also considers the etiology, pathogenesis, features of the course, diagnosis, and treatment of patients with neuro-AIDS.
Style APA, Harvard, Vancouver, ISO itp.
9

Lim, Chai K., Bruce J. Brew, Gayathri Sundaram i Gilles J. Guillemin. "Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression". International Journal of Tryptophan Research 3 (styczeń 2010): IJTR.S4294. http://dx.doi.org/10.4137/ijtr.s4294.

Pełny tekst źródła
Streszczenie:
The kynurenine pathway (KP) is a major degradative pathway of tryptophan ultimately leading to the production of nicotinamide adenine dinucleotide (NAD+) and is also one of the major regulatory mechanisms of the immune response. The KP is known to be involved in several neuroinflammatory disorders including Alzheimer's disease, amyotrophic lateral sclerosis, AIDS dementia complex, Parkinson's disease, schizophrenia, Huntington's disease and brain tumours. However, the KP remains a relatively new topic for the field of multiple sclerosis (MS). Over the last 2–3 years, some evidence has progressively emerged suggesting that the KP is likely to be involved in the pathogenesis of autoimmune diseases especially MS. Some KP modulators are already in clinical trials for other inflammatory diseases and would potentially provide a new and important therapeutic strategy for MS patients. This review summarizes the known relationships between the KP and MS.
Style APA, Harvard, Vancouver, ISO itp.
10

Talley, A. K., S. Dewhurst, S. W. Perry, S. C. Dollard, S. Gummuluru, S. M. Fine, D. New, L. G. Epstein, H. E. Gendelman i H. A. Gelbard. "Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA." Molecular and Cellular Biology 15, nr 5 (maj 1995): 2359–66. http://dx.doi.org/10.1128/mcb.15.5.2359.

Pełny tekst źródła
Streszczenie:
Tumor necrosis factor alpha (TNF-alpha) is a candidate human immunodeficiency virus type 1-induced neurotoxin that contributes to the pathogenesis of AIDS dementia complex. We report here on the effects of exogenous TNF-alpha on SK-N-MC human neuroblastoma cells differentiated to a neuronal phenotype with retinoic acid, TNF-alpha caused a dose-dependent loss of viability and a corresponding increase in apoptosis in differentiated SK-N-MC cells but not in undifferentiated cultures. Importantly, intracellular signalling via TNF receptors, as measured by activation of the transcription factor NF-kappa B, was unaltered by retinoic acid treatment. Finally, overexpression of bcl-2 or crmA conferred resistance to apoptosis mediated by TNF-alpha, as did the addition of the antioxidant N-acetylcysteine. These results suggest that TNF-alpha induces apoptosis in neuronal cells by a pathway that involves formation of reactive oxygen intermediates and which can be blocked by specific genetic interventions.
Style APA, Harvard, Vancouver, ISO itp.
11

Portegies, Peter, i Nathalie R. Rosenberg. "AIDS Dementia Complex". CNS Drugs 9, nr 1 (1998): 31–40. http://dx.doi.org/10.2165/00023210-199809010-00004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

DeArmond, S. J. "Aids Dementia Complex". Microscopy and Microanalysis 5, S2 (sierpień 1999): 1090–91. http://dx.doi.org/10.1017/s1431927600018778.

Pełny tekst źródła
Streszczenie:
The World Health Organization estimates by the year 2000 that the cumulative total of HIV-1 infected adults and children will be about 30 million worldwide. Disease of the central nervous system (CNS) in association with AIDS is common. 20-30% of AIDS patients will develop varying degrees of cognitive and motor deficits designated the “AIDS dementia Complex (ADC)” or “HIV-1-associated cognitive/motor deficit”. Progression of symptoms is usually slow and irregular. In the end-stage, the patient is severely impaired with mutism, incontinence and prominent motor impairment. Neuroradiologic studies show generalized cortical atrophy and diffuse white matter changes. HIV can be cultured from the CSF. Neurologic involvement in pediatric AIDS is very common with CNS complications usually occurring within the first two postnatal years. Given the severeness of the dementia and motor dysfunction in ADC, one is struck by the paucity of neuropathological features. Hematoxylin and eosin stained sections reveal only three neuropathological features. First, there are small numbers of microglial nodules scattered in the white matter and sometimes in grey matter (Fig. 1). However, microglial nodules occur in virtually all viral infections of the CNS, including CMV micronodular encephalitis in AIDS patients.
Style APA, Harvard, Vancouver, ISO itp.
13

Katz, Anne. "AIDS Dementia Complex". Journal of Palliative Care 10, nr 1 (marzec 1994): 46–50. http://dx.doi.org/10.1177/082585979401000112.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Brew, Bruce James. "AIDS DEMENTIA COMPLEX". Neurologic Clinics 17, nr 4 (listopad 1999): 861–81. http://dx.doi.org/10.1016/s0733-8619(05)70170-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Prockop, Leon D. "AIDS dementia complex". Journal of Legal Medicine 9, nr 4 (grudzień 1988): 509–17. http://dx.doi.org/10.1080/01947648809513542.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Wilson, Susan E. "AIDS Dementia Complex". AIDS Patient Care 3, nr 5 (październik 1989): 20–22. http://dx.doi.org/10.1089/apc.1989.3.20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Weisberg, Leon A., i Web Ross. "AIDS dementia complex". Postgraduate Medicine 86, nr 1 (lipiec 1989): 213–20. http://dx.doi.org/10.1080/00325481.1989.11704337.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Vinters, Harry V. "The AIDS dementia complex". Annals of Neurology 21, nr 6 (czerwiec 1987): 612. http://dx.doi.org/10.1002/ana.410210618.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Price, R. W., i B. J. Brew. "The AIDS Dementia Complex". Journal of Infectious Diseases 158, nr 5 (1.11.1988): 1079–83. http://dx.doi.org/10.1093/infdis/158.5.1079.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Wu, Yun-Cheng, Yong-Bo Zhao, Meng-Guang Tang, Sandy Xinyu Zhang-Nunes i Justin C. McArthur. "AIDS dementia complex in China". Journal of Clinical Neuroscience 14, nr 1 (styczeń 2007): 8–11. http://dx.doi.org/10.1016/j.jocn.2005.07.012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Portegies, Peter, RoelienH Enting, MennoD de Jong, SvenA Danner, Peter Reiss, Jaap Goudsmit i JoepMA Lange. "AIDS dementia complex and didanosine". Lancet 344, nr 8924 (wrzesień 1994): 759. http://dx.doi.org/10.1016/s0140-6736(94)92252-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Perrella, Oreste, Alessandro Perrella, Marco Perrella, Costanza Sbreglia i Gugliemo Borgia. "Cytokines and AIDS dementia complex". AIDS 17, nr 1 (styczeń 2003): 134–36. http://dx.doi.org/10.1097/00002030-200301030-00022.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Morriss, R., i A. House. "Zidovudine in AIDS dementia complex." BMJ 299, nr 6709 (11.11.1989): 1218. http://dx.doi.org/10.1136/bmj.299.6709.1218-a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Baert, A. E. "Neuropathology of Aids and the Aids-dementia complex". Clinical Neurology and Neurosurgery 91, nr 4 (styczeń 1989): 370. http://dx.doi.org/10.1016/0303-8467(89)90043-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Buhrich, Neil. "HIV, Psychosis and AIDS Dementia Complex". Australasian Psychiatry 3, nr 4 (sierpień 1995): 238–39. http://dx.doi.org/10.3109/10398569509080418.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Buckingham, Stephan L., i Wilfred G. Van Gorp. "AIDS-Dementia Complex: Implications for Practice". Social Casework 69, nr 6 (czerwiec 1988): 371–75. http://dx.doi.org/10.1177/104438948806900608.

Pełny tekst źródła
Streszczenie:
AIDS and the dementia associated with it have created new challenges for social workers. The authors identify unique issues around the AIDS-dementia complex. Implications for social work practice are discussed, and recommendations for assisting the growing population with this complex are made.
Style APA, Harvard, Vancouver, ISO itp.
27

Navia, Bradford A., Eun-Sook Cho, Carol K. Petito i Richard W. Price. "The AIDS dementia complex: II. Neuropathology". Annals of Neurology 19, nr 6 (czerwiec 1986): 525–35. http://dx.doi.org/10.1002/ana.410190603.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Maher, John, Rshujeel Choudhri, William Halliday, Christopher Power i Avindra Nath. "AIDS dementia complex with generalized myoclonus". Movement Disorders 12, nr 4 (lipiec 1997): 593–97. http://dx.doi.org/10.1002/mds.870120418.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

SCHARNHORST, SUSANNE. "AIDS Dementia Complex in the Elderly". Nurse Practitioner 17, nr 8 (sierpień 1992): 37,41–43. http://dx.doi.org/10.1097/00006205-199208000-00015.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Patton, Holly K., Etty Benveniste i Dale J. Benos. "Astrocytes and the AIDS Dementia Complex". Journal of Neuro-AIDS 1, nr 1 (12.10.1995): 111–31. http://dx.doi.org/10.1300/j128v01n01_06.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Meehan, Rebecca A., i Jennifer A. Brush. "An overview of AIDS dementia complex". American Journal of Alzheimer's Disease & Other Dementiasr 16, nr 4 (lipiec 2001): 225–29. http://dx.doi.org/10.1177/153331750101600411.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Katz, Anne. "Delayed Diagnosis of AIDS Dementia Complex". AIDS Patient Care 8, nr 4 (sierpień 1994): 183–84. http://dx.doi.org/10.1089/apc.1994.8.183.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Verma, R. C., L. R. Bennett, M. P. Can, G. Mathiesen, F. Kiouraehr, W. Riege, C. Wasterlain i F. D. Jones. "NONINVASIVE EVALUATION OF AIDS DEMENTIA COMPLEX". Clinical Nuclear Medicine 14, Supplement (wrzesień 1989): P12. http://dx.doi.org/10.1097/00003072-198909001-00013.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Price, Richard W. "The AIDS dementia complex: Current status". Journal of Neuroimmunology 16, nr 1 (wrzesień 1987): 4. http://dx.doi.org/10.1016/0165-5728(87)90136-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Ho, David D. "The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex". Annals of Internal Medicine 111, nr 5 (1.09.1989): 400. http://dx.doi.org/10.7326/0003-4819-111-5-400.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Price, Richard W., John Sidtis i Marc Rosenblum. "The aids dementia complex: Some current questions". Annals of Neurology 23, S1 (1988): S27—S33. http://dx.doi.org/10.1002/ana.410230711.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Navia, Bradford A., Barry D. Jordan i Richard W. Price. "The AIDS dementia complex: I. Clinical features". Annals of Neurology 19, nr 6 (czerwiec 1986): 517–24. http://dx.doi.org/10.1002/ana.410190602.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

von Einsiedel, R. Grafin, E. Minami, D. L. Secor, S. Pang, I. S. Y. Chen i H. V. Vinters. "STRUCTURAL COMPONENTS OF THE AIDS DEMENTIA COMPLEX". Journal of Neuropathology and Experimental Neurology 49, nr 3 (maj 1990): 351. http://dx.doi.org/10.1097/00005072-199005000-00277.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Portegies, Peter, Roelien H. Enting, Jan de Gans, Paul R. Algra, Mayke M. A. Derix, Joep M. A. Lange i Jaap Goudsmit. "Presentation and course of AIDS dementia complex". AIDS 7, nr 5 (maj 1993): 669–76. http://dx.doi.org/10.1097/00002030-199305000-00010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Tross, Susan, Richard W. Price, Bradford Navia, Howard T. Thaler, Jonathan Gold, Dan Alan Hirsch i John J. Sidtis. "Neuropsychological characterization of the AIDS dementia complex". AIDS 2, nr 2 (kwiecień 1988): 81–88. http://dx.doi.org/10.1097/00002030-198804000-00002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Chiesi, A., S. Vella, L. G. Dally, C. Pedersen, S. Danner, A. M. Johnson, S. Schwander, F. D. Goebel, M. Glauser i F. Antunes. "Epidemiology of AIDS Dementia Complex in Europe". Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11, nr 1 (styczeń 1996): 39–44. http://dx.doi.org/10.1097/00042560-199601010-00005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Schutzer, Steven E. "234 Autoimmune role in AIDS dementia complex". Journal of Allergy and Clinical Immunology 81, nr 1 (styczeń 1988): 227. http://dx.doi.org/10.1016/0091-6749(88)90469-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Fiala, Milan, Elyse J. Singer, Michael C. Graves, Wallace W. Tourtellotte, John A. Stewart, Charles A. Schable, Roy H. Rhodes i Harry V. Vinters. "AIDS dementia complex complicated by cytomegalovirus encephalopathy". Journal of Neurology 240, nr 4 (1993): 223–31. http://dx.doi.org/10.1007/bf00818709.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Estep, G. "The aids dementia complex: I. Clinical features". Journal of Emergency Medicine 5, nr 2 (styczeń 1987): 166. http://dx.doi.org/10.1016/0736-4679(87)90098-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Jubelt, Burk. "Abacavir for treatment of AIDS dementia complex". Current Neurology and Neuroscience Reports 1, nr 6 (listopad 2001): 516–17. http://dx.doi.org/10.1007/s11910-001-0055-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Kim, Dennis M., Robert Tien, Christopher Byrum i K. Ranga Rama Krishnan. "Imaging in acquired immune deficiency syndrome dementia complex (AIDS dementia complex): A review". Progress in Neuro-Psychopharmacology and Biological Psychiatry 20, nr 3 (kwiecień 1996): 349–70. http://dx.doi.org/10.1016/0278-5846(96)00002-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Power, Christopher, i Richard T. Johnson. "HIV-1 Associated Dementia: Clinical Features and Pathogenesis". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 22, nr 2 (maj 1995): 92–100. http://dx.doi.org/10.1017/s0317167100040154.

Pełny tekst źródła
Streszczenie:
AbstractHIV-1 infection is characterized by multiple neurological syndromes occuring at all stages of infection. HIV-1-associated dementia, however, is the most devastating CNS consequence of AIDS because of its poor prognosis and functional impairment. A clinical triad of progressive cognitive decline, motor dysfunction, and behavioural abnormalities typifies this subcortical dementia which eventually affects 15 to 20% of AIDS patients. Neuroimaging, CSF studies and neuropsychological testing are frequently required in diagnosing HIV-associated dementia, to exclude other conditions including psychiatric illnesses, opportunistic diseases and systemic disorders. The pathogenesis of HIV dementia is uncertain and there is evidence that multiple mechanisms of neurological injury occur. These mechanisms include: the role of neurovirulent strains of HIV; the potential neurotoxicity of HIV gp120, nitric oxide and quinolinic acid; immunologically mediated CNS injury through the action of cytokines and arachidonic acid metabolites; and altered blood-brain barrier permeability. A collective approach involving clinical studies,in vitroassays and animal models will provide greater insight into the pathogenesis and the rational development of therapy for HIV dementia.
Style APA, Harvard, Vancouver, ISO itp.
48

&NA;. "Zidovudine may delay onset of AIDS dementia complex". Inpharma Weekly &NA;, nr 1022 (luty 1996): 16. http://dx.doi.org/10.2165/00128413-199610220-00031.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Brew, Bruce J. "HAART in AIDS dementia complex and palliative care". Progress in Palliative Care 12, nr 4 (sierpień 2004): 171–77. http://dx.doi.org/10.1179/096992604225006370.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Rottenberg, D. A., J. R. Moeller, S. C. Strother, J. J. Sidtis, B. A. Navia, V. Dhawan, J. Z. Ginos i R. W. Price. "The metabolic pathology of the AIDS dementia complex". Annals of Neurology 22, nr 6 (grudzień 1987): 700–706. http://dx.doi.org/10.1002/ana.410220605.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „AIDS dementia complex - Pathogenesis” dla innych typów źródeł:
Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii